On a shop­ping spree, Al­ler­gan bags CoolSculpt­ing tech in $2.5B buy­out; Ake­bia strikes re­search deal with J&J

• Botox-mak­er Al­ler­gan has bagged a new com­pa­ny for its med­ical aes­thet­ics port­fo­lio, pay­ing $2.47 bil­lion for Pleasan­ton, CA-based Zel­tiq Aes­thet­ics $ZLTQ. Zel­tiq made its rep with what it calls “CoolSculpt­ing” tech, elim­i­nat­ing pock­ets of fat by cool­ing down fat cells. Al­ler­gan has been on a shop­ping spree for more than a year now as it builds up a pipeline of new drugs along­side its aes­thet­ics busi­ness.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.